Gregg Stanwood, Ph.D. - Publications

Affiliations: 
Pharmacology Vanderbilt University School of Medicine, Nashville, TN, United States 
Website:
http://www.mc.vanderbilt.edu/stanwoodlab

56 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Lee GS, Graham DL, Noble BL, Trammell TS, McCarthy DM, Anderson LR, Rubinstein M, Bhide PG, Stanwood GD. Behavioral and Neuroanatomical Consequences of Cell-Type Specific Loss of Dopamine D2 Receptors in the Mouse Cerebral Cortex. Frontiers in Behavioral Neuroscience. 15: 815713. PMID 35095443 DOI: 10.3389/fnbeh.2021.815713  0.494
2021 Graham DL, Madkour HS, Noble BL, Schatschneider C, Stanwood GD. Long-term functional alterations following prenatal GLP-1R activation. Neurotoxicology and Teratology. 87: 106984. PMID 33864929 DOI: 10.1016/j.ntt.2021.106984  0.428
2020 Trammell TS, Henderson NL, Madkour HS, Stanwood GD, Graham DL. GLP-1R activation alters performance in cognitive tasks in a sex-dependent manner. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. PMID 33222103 DOI: 10.1007/s10072-020-04910-8  0.375
2020 Graham DL, Durai HH, Trammell T, Noble BL, Mortlock DP, Galli A, Stanwood GD. A novel mouse model of glucagon-like peptide-1 receptor expression: a look at the brain. The Journal of Comparative Neurology. PMID 32170734 DOI: 10.1002/Cne.24905  0.463
2019 Goldfarb SS, Stanwood GD, Flynn HA, Graham DL. Developmental opioid exposures: Neurobiological underpinnings, behavioral impacts, and policy implications. Experimental Biology and Medicine (Maywood, N.J.). 1535370219883601. PMID 31630569 DOI: 10.1177/1535370219883601  0.413
2017 Zike ID, Chohan MO, Kopelman JM, Krasnow EN, Flicker D, Nautiyal KM, Bubser M, Kellendonk C, Jones CK, Stanwood G, Tanaka KF, Moore H, Ahmari SE, Veenstra-VanderWeele J. OCD candidate gene SLC1A1/EAAT3 impacts basal ganglia-mediated activity and stereotypic behavior. Proceedings of the National Academy of Sciences of the United States of America. PMID 28507136 DOI: 10.1073/Pnas.1701736114  0.407
2016 Muller CL, Anacker AM, Rogers TD, Goeden N, Keller EH, Forsberg CG, Kerr TM, Wender C, Anderson GM, Stanwood GD, Blakely RD, Bonnin A, Veenstra-VanderWeele J. Impact of Maternal Serotonin Transporter Genotype on Placental Serotonin, Fetal Forebrain Serotonin, and Neurodevelopment. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 27550733 DOI: 10.1038/Npp.2016.166  0.511
2016 Martin MM, Graham DL, McCarthy DM, Bhide PG, Stanwood GD. Cocaine-induced neurodevelopmental deficits and underlying mechanisms. Birth Defects Research. Part C, Embryo Today : Reviews. 108: 147-73. PMID 27345015 DOI: 10.1002/bdrc.21132  0.552
2016 Reddy IA, Pino JA, Weikop P, Osses N, Sørensen G, Bering T, Valle C, Bluett RJ, Erreger K, Wortwein G, Reyes JG, Graham D, Stanwood GD, Hackett TA, Patel S, et al. Glucagon-like peptide 1 receptor activation regulates cocaine actions and dopamine homeostasis in the lateral septum by decreasing arachidonic acid levels. Translational Psychiatry. 6: e809. PMID 27187231 DOI: 10.1038/Tp.2016.86  0.555
2015 Sørensen G, Reddy IA, Weikop P, Graham DL, Stanwood GD, Wortwein G, Galli A, Fink-Jensen A. The glucagon-like peptide 1 (GLP-1) receptor agonist exendin-4 reduces cocaine self-administration in mice. Physiology & Behavior. 149: 262-8. PMID 26072178 DOI: 10.1016/J.Physbeh.2015.06.013  0.581
2015 Graham DL, Buendia MA, Chapman MA, Durai HH, Stanwood GD. Deletion of Gαq in the telencephalon alters specific neurobehavioral outcomes. Synapse (New York, N.Y.). PMID 25963901 DOI: 10.1002/syn.21830  0.465
2015 Frederick AL, Yano H, Trifilieff P, Vishwasrao HD, Biezonski D, Mészáros J, Urizar E, Sibley DR, Kellendonk C, Sonntag KC, Graham DL, Colbran RJ, Stanwood GD, Javitch JA. Evidence against dopamine D1/D2 receptor heteromers. Molecular Psychiatry. PMID 25560761 DOI: 10.1038/Mp.2014.166  0.746
2015 Graham DL, Durai HH, Garden JD, Cohen EL, Echevarria FD, Stanwood GD. Loss of dopamine D2 receptors increases parvalbumin-positive interneurons in the anterior cingulate cortex. Acs Chemical Neuroscience. 6: 297-305. PMID 25393953 DOI: 10.1021/cn500235m  0.557
2015 Ross EJ, Graham DL, Money KM, Stanwood GD. Developmental consequences of fetal exposure to drugs: what we know and what we still must learn. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 61-87. PMID 24938210 DOI: 10.1038/npp.2014.147  0.49
2015 Sørensen G, Reddy IA, Weikop P, Graham DL, Stanwood GD, Wortwein G, Galli A, Fink-Jensen A. The glucagon-like peptide 1 (GLP-1) receptor agonist exendin-4 reduces cocaine self-administration in mice Physiology and Behavior. 149: 262-268. DOI: 10.1016/j.physbeh.2015.06.013  0.498
2015 Ross E, Graham D, Stanwood G. Developmental dopamine D2 receptor effects on interneuron development and behavior Neurotoxicology and Teratology. 49: 131. DOI: 10.1016/J.Ntt.2015.04.100  0.588
2015 Graham D, Durai H, Garden J, Cohen E, Echevarria F, Stanwood G. NTX25Loss of dopamine D2 receptors increases parvalbumin-positive interneurons in the anterior cingulate cortex Neurotoxicology and Teratology. 49: 108. DOI: 10.1016/J.Ntt.2015.04.031  0.557
2013 Money KM, Stanwood GD. Developmental origins of brain disorders: roles for dopamine. Frontiers in Cellular Neuroscience. 7: 260. PMID 24391541 DOI: 10.3389/fncel.2013.00260  0.34
2013 Graham DL, Erreger K, Galli A, Stanwood GD. GLP-1 analog attenuates cocaine reward. Molecular Psychiatry. 18: 961-2. PMID 23089631 DOI: 10.1038/Mp.2012.141  0.55
2012 Killinger CE, Robinson S, Stanwood GD. Subtle biobehavioral effects produced by paternal cocaine exposure. Synapse (New York, N.Y.). 66: 902-8. PMID 22807092 DOI: 10.1002/syn.21582  0.761
2012 Frederick AL, Saborido TP, Stanwood GD. Neurobehavioral phenotyping of G(αq) knockout mice reveals impairments in motor functions and spatial working memory without changes in anxiety or behavioral despair. Frontiers in Behavioral Neuroscience. 6: 29. PMID 22723772 DOI: 10.3389/Fnbeh.2012.00029  0.715
2012 Carpenter AC, Saborido TP, Stanwood GD. Development of hyperactivity and anxiety responses in dopamine transporter-deficient mice. Developmental Neuroscience. 34: 250-7. PMID 22572477 DOI: 10.1016/J.Ntt.2013.03.053  0.396
2012 Graham D, Sprinkel K, Buendia M, Saborido T, Stanwood G. Dopamine receptor reporter mice: Are they useful as a tool for developmental pharmacological and behavioral studies? Neurotoxicology and Teratology. 34: 384. DOI: 10.1016/J.Ntt.2012.05.051  0.426
2011 Gustin RM, Shonesy BC, Robinson SL, Rentz TJ, Baucum AJ, Jalan-Sakrikar N, Winder DG, Stanwood GD, Colbran RJ. Loss of Thr286 phosphorylation disrupts synaptic CaMKIIα targeting, NMDAR activity and behavior in pre-adolescent mice. Molecular and Cellular Neurosciences. 47: 286-92. PMID 21627991 DOI: 10.1016/J.Mcn.2011.05.006  0.405
2011 Frederick A, Saborido T, Baucum A, Colbran R, Stanwood G. Potential Dopamine D1 Receptor Signaling Through Gaq: Behavioral and Biochemical Assessment Neurotoxicology and Teratology. 33: 510-511. DOI: 10.1016/J.Ntt.2011.05.065  0.742
2011 Stanwood G. Dopaminergic Regulation of Brain Architecture, Pharmacological Responsiveness, and Behavior: Long-Lasting Neuromaladaptions following In Utero Cocaine Neurotoxicology and Teratology. 33: 504. DOI: 10.1016/J.Ntt.2011.05.045  0.444
2011 Saborido T, Bluett R, Bermingham D, Killinger C, Durai H, Stanwood G. Behavioral Effects of 5-HT6 Receptor Ligands and Relationship to Brain Dopamine Systems Neurotoxicology and Teratology. 33: 498. DOI: 10.1016/J.Ntt.2011.05.026  0.755
2010 Swant J, Chirwa S, Stanwood G, Khoshbouei H. Methamphetamine reduces LTP and increases baseline synaptic transmission in the CA1 region of mouse hippocampus. Plos One. 5: e11382. PMID 20614033 DOI: 10.1371/Journal.Pone.0011382  0.374
2010 Thompson BL, Stanwood GD, Levitt P. Specificity of prenatal cocaine exposure effects on cortical interneurons is independent from dopamine D1 receptor co-localization. Journal of Chemical Neuroanatomy. 39: 228-34. PMID 20080176 DOI: 10.1016/j.jchemneu.2010.01.002  0.735
2010 Kern CH, Stanwood GD, Smith DR. Preweaning manganese exposure causes hyperactivity, disinhibition, and spatial learning and memory deficits associated with altered dopamine receptor and transporter levels. Synapse (New York, N.Y.). 64: 363-78. PMID 20029834 DOI: 10.1002/syn.20736  0.348
2010 Frederick A, Colbran R, Stanwood G. Molecular (mal)adaptations in dopamine-modulated signaling pathways following neurodevelopmental insult Neurotoxicology and Teratology. 32: 510. DOI: 10.1016/J.Ntt.2010.04.049  0.713
2009 Stanwood GD, Leitch DB, Savchenko V, Wu J, Fitsanakis VA, Anderson DJ, Stankowski JN, Aschner M, McLaughlin B. Manganese exposure is cytotoxic and alters dopaminergic and GABAergic neurons within the basal ganglia. Journal of Neurochemistry. 110: 378-89. PMID 19457100 DOI: 10.1111/J.1471-4159.2009.06145.X  0.554
2009 Frederick AL, Stanwood GD. Drugs, biogenic amine targets and the developing brain. Developmental Neuroscience. 31: 7-22. PMID 19372683 DOI: 10.1159/000207490  0.706
2009 Thompson BL, Levitt P, Stanwood GD. Prenatal exposure to drugs: effects on brain development and implications for policy and education. Nature Reviews. Neuroscience. 10: 303-12. PMID 19277053 DOI: 10.1038/nrn2598  0.641
2009 Thompson BL, Stanwood GD. Pleiotropic effects of neurotransmission during development: modulators of modularity. Journal of Autism and Developmental Disorders. 39: 260-8. PMID 18648918 DOI: 10.1007/s10803-008-0624-0  0.57
2008 Couppis MH, Kennedy CH, Stanwood GD. Differences in aggressive behavior and in the mesocorticolimbic DA system between A/J and BALB/cJ mice. Synapse (New York, N.Y.). 62: 715-24. PMID 18651644 DOI: 10.1002/Syn.20545  0.302
2008 Stankowski J, Leitch D, Aschner M, McLaughlin B, Stanwood GD. Selective vulnerability of dopaminergic systems to Manganese: Relevance to occupational exposure Neurotoxicology and Teratology. 30: 259. DOI: 10.1016/J.Ntt.2008.03.056  0.533
2008 Parlaman J, Stanwood G. Biochemical consequences of altered dopamine D1 receptor signalling in the brain Neurotoxicology and Teratology. 30: 257-258. DOI: 10.1016/J.Ntt.2008.03.051  0.447
2007 Maple AM, Perna MK, Parlaman JP, Stanwood GD, Brown RW. Ontogenetic quinpirole treatment produces long-lasting decreases in the expression of Rgs9, but increases Rgs17 in the striatum, nucleus accumbens and frontal cortex. The European Journal of Neuroscience. 26: 2532-8. PMID 17970732 DOI: 10.1111/J.1460-9568.2007.05860.X  0.335
2007 Parlaman JP, Thompson BL, Levitt P, Stanwood GD. Pharmacokinetic profile of cocaine following intravenous administration in the female rabbit. European Journal of Pharmacology. 563: 124-9. PMID 17383635 DOI: 10.1016/j.ejphar.2007.02.035  0.677
2007 Stanwood GD, Levitt P. Waved-1 mutant mice are hypersensitive to the locomotor actions of cocaine. Synapse (New York, N.Y.). 61: 259-62. PMID 17230552 DOI: 10.1002/syn.20364  0.562
2007 Stanwood GD, Levitt P. Prenatal exposure to cocaine produces unique developmental and long-term adaptive changes in dopamine D1 receptor activity and subcellular distribution. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 152-7. PMID 17202482 DOI: 10.1523/JNEUROSCI.4591-06.2007  0.609
2006 Stanwood GD, Parlaman JP, Levitt P. Genetic or pharmacological inactivation of the dopamine D1 receptor differentially alters the expression of regulator of G-protein signalling (Rgs) transcripts. The European Journal of Neuroscience. 24: 806-18. PMID 16930410 DOI: 10.1111/j.1460-9568.2006.04970.x  0.612
2005 Thompson BL, Levitt P, Stanwood GD. Prenatal cocaine exposure specifically alters spontaneous alternation behavior. Behavioural Brain Research. 164: 107-16. PMID 16054247 DOI: 10.1016/j.bbr.2005.06.010  0.701
2005 Stanwood GD, Parlaman JP, Levitt P. Anatomical abnormalities in dopaminoceptive regions of the cerebral cortex of dopamine D1 receptor mutant mice. The Journal of Comparative Neurology. 487: 270-82. PMID 15892099 DOI: 10.1002/cne.20548  0.579
2004 Stanwood GD, Levitt P. Drug exposure early in life: functional repercussions of changing neuropharmacology during sensitive periods of brain development. Current Opinion in Pharmacology. 4: 65-71. PMID 15018841 DOI: 10.1016/j.coph.2003.09.003  0.491
2003 Stanwood GD, Levitt P. Repeated i.v. cocaine exposure produces long-lasting behavioral sensitization in pregnant adults, but behavioral tolerance in their offspring. Neuroscience. 122: 579-83. PMID 14622900 DOI: 10.1016/j.neuroscience.2003.08.029  0.579
2003 Powell EM, Campbell DB, Stanwood GD, Davis C, Noebels JL, Levitt P. Genetic disruption of cortical interneuron development causes region- and GABA cell type-specific deficits, epilepsy, and behavioral dysfunction. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 622-31. PMID 12533622  0.649
2002 Rittenhouse PA, López-Rubalcava C, Stanwood GD, Lucki I. Amplified behavioral and endocrine responses to forced swim stress in the Wistar-Kyoto rat. Psychoneuroendocrinology. 27: 303-18. PMID 11818168 DOI: 10.1016/S0306-4530(01)00052-X  0.668
2001 Stanwood GD, Washington RA, Shumsky JS, Levitt P. Prenatal cocaine exposure produces consistent developmental alterations in dopamine-rich regions of the cerebral cortex. Neuroscience. 106: 5-14. PMID 11564412 DOI: 10.1016/S0306-4522(01)00256-1  0.727
2001 Mirnics K, Middleton FA, Stanwood GD, Lewis DA, Levitt P. Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia. Molecular Psychiatry. 6: 293-301. PMID 11326297 DOI: 10.1038/Sj.Mp.4000866  0.616
2001 Stanwood GD, Washington RA, Levitt P. Identification of a sensitive period of prenatal cocaine exposure that alters the development of the anterior cingulate cortex. Cerebral Cortex (New York, N.Y. : 1991). 11: 430-40. PMID 11313295 DOI: 10.1093/cercor/11.5.430  0.526
2000 Stanwood GD, Lucki I, McGonigle P. Differential regulation of dopamine D2 and D3 receptors by chronic drug treatments. The Journal of Pharmacology and Experimental Therapeutics. 295: 1232-40. PMID 11082460  0.57
2000 Stanwood GD, Artymyshyn RP, Kung MP, Kung HF, Lucki I, McGonigle P. Quantitative autoradiographic mapping of rat brain dopamine D3 binding with [(125)I]7-OH-PIPAT: evidence for the presence of D3 receptors on dopaminergic and nondopaminergic cell bodies and terminals. The Journal of Pharmacology and Experimental Therapeutics. 295: 1223-31. PMID 11082459  0.57
2000 Jones LB, Stanwood GD, Reinoso BS, Washington RA, Wang HY, Friedman E, Levitt P. In utero cocaine-induced dysfunction of dopamine D1 receptor signaling and abnormal differentiation of cerebral cortical neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 4606-14. PMID 10844030  0.349
2000 Pearl SM, Antion MD, Stanwood GD, Jaumotte JD, Kapatos G, Zigmond MJ. Effects of NADH on dopamine release in rat striatum. Synapse (New York, N.Y.). 36: 95-101. PMID 10767056 DOI: 10.1002/(Sici)1098-2396(200005)36:2<95::Aid-Syn2>3.0.Co;2-U  0.509
Show low-probability matches.